DA
MRNA icon

Denali Advisors’s Moderna MRNA Stock Holding History

Denali Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,200
Closed -$146K – 516
2023
Q2 		$146K Hold
1,200
– – 0.05% 242
2023
Q1 		$184K Buy
1,200
+600
+100% +$99K 0.08% 154
2022
Q4 		$108K Sell
600
-500
-45% -$81.8K 0.05% 167
2022
Q3 		$130K Buy
1,100
+700
+175% +$106K 0.06% 154
2022
Q2 		$57K Buy
+400
New +$57.2K 0.02% 206

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Denali Advisors's MRNA Position: Q3 2023 in Review

Denali Advisors sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,200 shares — an estimated $146K sold.

Denali Advisors first reported a position in MRNA in Q2 2022 and held it in 5 quarters. The position peaked at $184K in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Denali Advisors reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Denali Advisors sold 1,200 Moderna shares in Q3 2023, an estimated $146K.
  • Denali Advisors first reported a position in Moderna in Q2 2022 and held it in 5 quarters.
  • Denali Advisors's Moderna position peaked at $184K in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Denali Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.